South San Francisco, CA, United States of America

Min Zhong

This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Assembly Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Zhong. Retrieved from https://idiyas.com/inventor/min-zhong-lhfh85m3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Zhong: Innovator in Hepatitis B Treatment

Introduction

Min Zhong is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of Hepatitis B virus (HBV). His innovative work has led to the development of novel compounds that hold promise for effective treatment options.

Latest Patents

Min Zhong holds a patent for "5-Membered Heteroaryl Carboxamide Compounds for Treatment of HBV." This patent represents a crucial advancement in the search for effective therapies against HBV, showcasing his commitment to addressing critical health challenges.

Career Highlights

Min Zhong is currently associated with Assembly Biosciences, Inc., where he continues to push the boundaries of research and development in the pharmaceutical industry. His work at the company emphasizes the importance of innovation in creating new treatment modalities for viral infections.

Conclusion

Min Zhong's contributions to the field of medicine, particularly through his patent and work at Assembly Biosciences, Inc., highlight his role as a key innovator in the fight against Hepatitis B. His dedication to advancing medical science is commendable and reflects the impact of inventors in improving global health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…